A Follow-up Study to Evaluate Actinic Keratosis Recurrence Rates One Year After Completion of the 1487-IMIQ Study
Latest Information Update: 01 Dec 2016
At a glance
- Drugs Imiquimod (Primary)
- Indications Actinic keratosis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Meda Pharma GmbH & Co KG
Most Recent Events
- 16 Nov 2016 New trial record